128 related articles for article (PubMed ID: 1732633)
1. The effect of pH on the in vitro colony forming ability of transitional cell carcinoma cells treated with various chemotherapeutic agents: implications for in vivo therapy.
Tarkington M; Sommers CL; Gelmann EP; Tefft MC; Lynch JH
J Urol; 1992 Feb; 147(2):511-3. PubMed ID: 1732633
[TBL] [Abstract][Full Text] [Related]
2. Intravesical chemotherapy: studies on the relationship between osmolality and cytotoxicity.
Groos E; Masters JR
J Urol; 1986 Aug; 136(2):399-402. PubMed ID: 3090275
[TBL] [Abstract][Full Text] [Related]
3. Intravesical chemotherapy. Studies on the relationship between pH and cytotoxicity.
Groos E; Walker L; Masters JR
Cancer; 1986 Sep; 58(6):1199-203. PubMed ID: 3091241
[TBL] [Abstract][Full Text] [Related]
4. Sensitivities of monolayers and spheroids of the human bladder cancer cell line MGH-U1 to the drugs used for intravesical chemotherapy.
Knuchel R; Hofstadter F; Jenkins WE; Masters JR
Cancer Res; 1989 Mar; 49(6):1397-401. PubMed ID: 2493980
[TBL] [Abstract][Full Text] [Related]
5. In vitro study of the interaction of doxorubicin, thiotepa, and mitomycin-C, agents used for intravesical chemotherapy of superficial bladder cancer.
Seraphim LA; Perrapato SD; Slocum HK; Rustum YM; Huben RP
J Urol; 1991 Mar; 145(3):613-7. PubMed ID: 1900087
[TBL] [Abstract][Full Text] [Related]
6. [Chemosensitivity in established human bladder carcinoma and HELA cell lines in vitro].
Uchibayashi T
Nihon Hinyokika Gakkai Zasshi; 1983 Sep; 74(9):1606-20. PubMed ID: 6202921
[No Abstract] [Full Text] [Related]
7. Interferons modify in vitro proliferation of human bladder transitional cell carcinoma in the presence of doxorubicin and mitomycin C.
Okamoto E; Kinne RK; Sökeland J
J Urol; 1996 Oct; 156(4):1492-5. PubMed ID: 8808915
[TBL] [Abstract][Full Text] [Related]
8. Transitional explant reduction assay--a new in vitro testing system for intravesical chemotherapy.
Weaver DJ; Barrett BA; Ross G; Adelstein EH
J Urol; 1986 Feb; 135(2):386-91. PubMed ID: 3080606
[TBL] [Abstract][Full Text] [Related]
9. In vitro chemosensitivity of human bladder cancer.
Weisenthal LM; Lalude AO; Miller JB
Cancer; 1983 Apr; 51(8):1490-6. PubMed ID: 6186358
[TBL] [Abstract][Full Text] [Related]
10. Cytomorphological lesions induced by chemotherapeutic agents in transitional cell carcinoma in vitro.
Weaver DJ; Barrett BA; Ross G; Adelstein EH
In Vitro Cell Dev Biol; 1986 Nov; 22(11):653-60. PubMed ID: 3096952
[TBL] [Abstract][Full Text] [Related]
11. Transitional cell carcinoma of the prostate following intravesical therapy for transitional cell carcinoma of the bladder.
Hardeman SW; Perry A; Soloway MS
J Urol; 1988 Aug; 140(2):289-92. PubMed ID: 3135420
[TBL] [Abstract][Full Text] [Related]
12. Distilled water versus chemotherapeutic agents for transitional bladder carcinoma.
Levin DR; Moskovitz B
Eur Urol; 1986; 12(6):418-21. PubMed ID: 3102241
[TBL] [Abstract][Full Text] [Related]
13. Verapamil enhanced in vitro chemosensitivity of a murine bladder carcinoma, FCB.
Ballou RJ; Simpson WG; Harty JI; Tseng MT
Urol Res; 1986; 14(4):195-200. PubMed ID: 3097900
[TBL] [Abstract][Full Text] [Related]
14. [Study of the synergy of microwave hyperthermia/intravesical chemotherapy in the prevention of recurrences of superficial tumors of the bladder].
Mauroy B; Bonnal JL; Prevost B; Chive M; Lhotellier V; Sozanski JP; Vanseymortier L; Stefaniak X
Prog Urol; 1999 Feb; 9(1):69-80. PubMed ID: 10212955
[TBL] [Abstract][Full Text] [Related]
15. [Overexpression of PTEN gene inhibits proliferation of bladder transitional carcinoma cell line EJ].
Qiao BM; Sun G; Tang Y; Chang JW; Wang WC; Ma TX
Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):262-5. PubMed ID: 17760251
[TBL] [Abstract][Full Text] [Related]
16. Different pH dependency of mitomycin C activity in monolayer and three-dimensional cultures.
Yen WC; Schmittgen T; Au JL
Pharm Res; 1996 Dec; 13(12):1887-91. PubMed ID: 8987090
[TBL] [Abstract][Full Text] [Related]
17. [Sensitivity tests of anti-cancer drugs with human tumor stem cell assay. 2. The results in renal cell carcinoma and urothelial carcinoma].
Sakuramoto T; Miura T; Kubota Y
Nihon Hinyokika Gakkai Zasshi; 1985 May; 76(5):645-8. PubMed ID: 4057715
[No Abstract] [Full Text] [Related]
18. Intravesical chemotherapy: in vitro studies on the relationship between dose and cytotoxicity.
Walker MC; Masters JR; Parris CN; Hepburn PJ; English PJ
Urol Res; 1986; 14(3):137-40. PubMed ID: 3092427
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the cytotoxic activities of chemotherapeutic drugs using a human bladder cancer cell line.
Hepburn PJ; Oliver RT; Riley PA; Hill BT; Masters JR
Urol Res; 1985; 13(1):27-34. PubMed ID: 4039488
[TBL] [Abstract][Full Text] [Related]
20. Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
Naito S; Hasegawa S; Yokomizo A; Koga H; Kotoh S; Kuwano M; Kumazawa J
Jpn J Cancer Res; 1995 Nov; 86(11):1112-8. PubMed ID: 8567404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
